Ofri Mosenzon Selected Research

Contraindications

10/2020

Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ofri Mosenzon Research Topics

Disease

80	Type 2 Diabetes Mellitus (MODY) 10/2023 - 10/2013
35	Myocardial Infarction 01/2023 - 10/2013
33	Heart Failure 01/2023 - 10/2013
22	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 03/2016
19	Diabetes Mellitus 11/2021 - 10/2014
14	Chronic Renal Insufficiency 10/2023 - 10/2014
14	Kidney Diseases (Kidney Disease) 10/2023 - 01/2018
12	Ischemic Stroke 01/2023 - 06/2015
9	Weight Loss (Weight Reduction) 01/2023 - 01/2018
8	Body Weight (Weight, Body) 01/2023 - 11/2020
7	Obesity 10/2023 - 01/2018
7	Hypoglycemia (Reactive Hypoglycemia) 07/2023 - 08/2016
7	Albuminuria 01/2023 - 04/2015
7	Stroke (Strokes) 01/2023 - 10/2013
5	Diabetic Nephropathies (Diabetic Nephropathy) 10/2022 - 01/2017
4	Infections 01/2023 - 01/2019
4	Overweight 01/2022 - 01/2020
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 11/2014
4	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 01/2021 - 01/2019
3	Heart Diseases (Heart Disease) 10/2023 - 01/2023
3	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2020
3	Nausea 01/2022 - 01/2018
3	Body Weight Changes 04/2021 - 01/2020
3	Atrial Fibrillation 01/2021 - 11/2019
3	Pancreatitis 11/2020 - 10/2013
2	Nutrition Disorders (Nutritional Disorders) 01/2023 - 01/2023
2	Neoplasms (Cancer) 01/2023 - 01/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2019
2	Glycosuria 10/2021 - 01/2018
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2021 - 11/2020
2	Renal Insufficiency (Renal Failure) 01/2018 - 08/2016
2	Chronic Pancreatitis 09/2014 - 10/2013
1	Systolic Heart Failure 10/2023
1	Sleepiness 04/2023
1	Pain (Aches) 04/2023
1	Chronic Pain 04/2023
1	Hypotension (Low Blood Pressure) 01/2023
1	Vomiting 01/2022
1	Constipation 01/2022
1	Asthma (Bronchial Asthma) 11/2021
1	Insulin Resistance 10/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Coma (Comas) 01/2021

Drug/Important Bio-Agent (IBA)

32	dapagliflozinIBA 10/2023 - 01/2018
23	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 08/2016
21	saxagliptin FDA Link 11/2021 - 10/2013
15	SodiumIBA 10/2023 - 01/2018
13	Sodium-Glucose Transport ProteinsIBA 10/2023 - 01/2019
13	semaglutideIBA 01/2023 - 01/2018
13	Liraglutide FDA Link 01/2022 - 01/2018
10	Insulin (Novolin)FDA Link 07/2023 - 11/2014
10	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2023 - 01/2018
10	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 01/2018
9	omega-Chloroacetophenone (Mace)IBA 01/2023 - 01/2018
8	CreatinineIBA 10/2023 - 01/2018
7	AlbuminsIBA 10/2023 - 01/2018
7	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 10/2023 - 01/2020
6	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 01/2018
6	Biomarkers (Surrogate Marker)IBA 11/2021 - 12/2016
6	Metformin (Glucophage)FDA LinkGeneric 04/2021 - 01/2019
5	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 12/2018
3	Hemoglobins (Hemoglobin)IBA 10/2023 - 01/2022
3	pro-brain natriuretic peptide (1-76)IBA 11/2021 - 01/2018
3	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2021 - 10/2014
3	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 08/2016
2	Mechanistic Target of Rapamycin Complex 1IBA 10/2023 - 01/2020
2	Insulin Glargine (Lantus)FDA Link 07/2023 - 01/2023
2	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2023 - 01/2017
2	SymportersIBA 01/2023 - 01/2021
2	empagliflozinIBA 01/2022 - 10/2021
2	Exenatide (Byetta)FDA Link 01/2022 - 01/2019
2	Troponin T (Troponin T1)IBA 11/2021 - 12/2016
2	TicagrelorIBA 01/2021 - 01/2021
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2021
2	DiureticsIBA 01/2020 - 11/2016
1	finerenoneIBA 10/2023
1	Medical MarijuanaIBA 04/2023
1	CannabinoidsIBA 04/2023
1	Plant ExtractsIBA 04/2023
1	tirzepatideIBA 01/2023
1	Antihypertensive Agents (Antihypertensives)IBA 01/2023
1	Pioglitazone (Actos)FDA Link 01/2023
1	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2023
1	C-Reactive ProteinIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022
1	HDL CholesterolIBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	PotassiumIBA 01/2022
1	ORALIT (ORS)IBA 11/2021
1	Peptides (Polypeptides)IBA 04/2021
1	Sitagliptin Phosphate (Januvia)FDA Link 04/2021
1	Thyroid HormonesIBA 01/2021
1	Factor Xa (Coagulation Factor Xa)IBA 01/2021

Therapy/Procedure

12	Therapeutics 01/2022 - 01/2003
6	Glycemic Control 01/2023 - 01/2017
3	Surgical Amputation (Amputations) 01/2022 - 01/2020
3	Secondary Prevention 01/2021 - 01/2018
1	Drug Tapering 04/2023
1	Renal Dialysis (Hemodialysis) 04/2023